Jack Pieniazek
Family Medicine · Conroe, TXNPI 1164426870
Payments from drug & device makers
Across 144 payments — averaging $31.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$681
- AstraZeneca$639
- Novartis$474
- GSK$396
- Lilly USA, LLC$356
- Amarin Pharma, Inc.$343
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,601100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $681 |
| AstraZeneca(2 entities) | 21 | $639 |
| Novartis | 4 | $474 |
| GSK | 14 | $396 |
| Lilly USA, LLC | 15 | $356 |
| Amarin Pharma, Inc. | 10 | $343 |
| AbbVie(2 entities) | 12 | $248 |
| Vertiflex, Inc. | 5 | $245 |
| Boehringer Ingelheim | 7 | $208 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $206 |
| Johnson & Johnson | 9 | $192 |
| Novo Nordisk | 11 | $173 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $97 |
| Pfizer | 3 | $45 |
| Antares Pharma, Inc. | 3 | $45 |
| Abbott | 2 | $41 |
| Philips North America LLC | 1 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,607 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 115 | $121,136 |
| EliquisApixaban | 70 | $67,432 |
| TrulicityDulaglutide | 58 | $61,610 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $55,283 |
| JardianceEmpagliflozin | 15 | $21,921 |
| MounjaroTirzepatide | 18 | $18,471 |
| Atorvastatin Calcium | 470 | $14,536 |
| XareltoRivaroxaban | 11 | $10,194 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $7,511 |
| Rosuvastatin Calcium | 152 | $7,417 |
| Tamsulosin Hcl | 110 | $7,257 |
| Celecoxib | 126 | $6,870 |
| Sildenafil Citrate | 40 | $4,697 |
| Omeprazole | 120 | $4,107 |
| Pioglitazone Hcl | 93 | $3,929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $173 | $121,136115 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $356 | $80,08176 claims |
| PfizerEliquis | $45 | $67,43270 claims |
| GSKTrelegy Ellipta | $396 | $55,28353 claims |
| Boehringer IngelheimJardiance | $208 | $21,92115 claims |
| Johnson & JohnsonXarelto | $192 | $10,19411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Conroe
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.